Stock IDHC INTEGRATED DIAGNOSTICS HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Integrated Diagnostics Holdings plc

Equities

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Market Closed - London S.E.
Other stock markets
 11:35:05 2024-04-26 am EDT 		5-day change 1st Jan Change
0.3155 USD -8.42% Intraday chart for Integrated Diagnostics Holdings plc -9.86% -11.13%
Mar. 28 Integrated Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 28 Transcript : Integrated Diagnostics Holdings plc, 2023 Earnings Call, Mar 28, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,600 10,355 771 380.4 213 9,067 - -
Enterprise Value (EV) 1 9,076 9,572 -712.8 380.4 213 8,629 8,085 7,354
P/E ratio 18.8 x 17.4 x 0.55 x 0.7 x 0.42 x 11.6 x 8.11 x -
Yield - 4.45% 169% - - 6.91% 9.87% 12.6%
Capitalization / Revenue 4.31 x 3.9 x 0.15 x 0.11 x 0.05 x 1.67 x 1.38 x 1.19 x
EV / Revenue 4.08 x 3.6 x -0.14 x 0.11 x 0.05 x 1.59 x 1.23 x 0.96 x
EV / EBITDA 9.61 x 8.17 x -0.28 x 0.32 x 0.18 x 5.33 x 3.71 x 2.64 x
EV / FCF 18,748,476 x 12,526,030 x -298,616 x - - - - -
FCF Yield 0% 0% -0% - - - - -
Price to Book 4.33 x 4.56 x 0.3 x - - 2.57 x 2.24 x -
Nbr of stocks (in thousands) 600,000 600,000 600,000 600,000 600,000 600,000 - -
Reference price 2 16.00 17.26 1.285 0.6340 0.3550 15.11 15.11 15.11
Announcement Date 4/28/20 5/19/21 4/21/22 4/6/23 3/28/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,226 2,656 5,225 3,605 4,123 5,415 6,549 7,637
EBITDA 1 944.3 1,171 2,530 1,172 1,192 1,618 2,176 2,788
EBIT 1 790.8 985.5 2,291 832.2 737.8 1,088 1,721 2,224
Operating Margin 35.52% 37.11% 43.85% 23.08% 17.9% 20.1% 26.27% 29.13%
Earnings before Tax (EBT) 758.1 969.1 2,232 853.6 - - - -
Net income 1 510.9 594 1,413 541.1 - 822 982 1,282
Net margin 22.95% 22.37% 27.04% 15.01% - 15.18% 14.99% 16.79%
EPS 2 0.8525 0.9900 2.350 0.9000 0.8500 1.305 1.864 -
Free Cash Flow 484.1 764.1 2,387 - - - - -
FCF margin 21.74% 28.77% 45.69% - - - - -
FCF Conversion (EBITDA) 51.26% 65.26% 94.36% - - - - -
FCF Conversion (Net income) 94.75% 128.64% 168.98% - - - - -
Dividend per Share 2 - 0.7683 2.170 - - 1.044 1.491 1.908
Announcement Date 4/28/20 5/19/21 4/21/22 4/6/23 3/28/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 S2 2022 Q1 2022 Q2 2022 Q3 2023 Q1
Net sales 1 1,166 - 1,706 - - - 1,180 773.6 846.3 915.3
EBITDA 527.9 - 803 - - - - - - -
EBIT 1 424.4 - - - 729.1 - 396.4 166.1 186.4 128.8
Operating Margin 36.41% - - - - - 33.58% 21.47% 22.02% 14.07%
Earnings before Tax (EBT) - - 695.3 - - - - - - -
Net income 287.1 178.8 415.2 646.4 454.2 766.2 296.6 124.9 -18.19 -
Net margin 24.63% - 24.34% - - - 25.13% 16.15% -2.15% -
EPS 0.4800 0.2975 - 1.080 - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 4/28/20 9/2/20 5/19/21 9/2/21 11/16/21 4/21/22 6/8/22 9/12/22 11/17/22 6/1/23
1EGP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 524 784 1,484 - - 438 982 1,713
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 484 764 2,387 - - - - -
ROE (net income / shareholders' equity) 22.8% 26.5% 58.2% - - 25.2% 29.5% 33%
ROA (Net income/ Total Assets) 14.2% 15% 27.1% - - - - -
Assets 1 3,595 3,966 5,207 - - - - -
Book Value Per Share 2 3.690 3.780 4.300 - - 5.890 6.750 -
Cash Flow per Share 2 1.160 1.470 3.780 - - 1.700 2.580 3.390
Capex 1 213 118 253 - - 322 315 311
Capex / Sales 9.58% 4.46% 4.85% - - 5.94% 4.81% 4.08%
Announcement Date 4/28/20 5/19/21 4/21/22 4/6/23 3/28/24 - - -
1EGP in Million2EGP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Integrated Diagnostics Holdings plc

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.11 EGP
Average target price
32.81 EGP
Spread / Average Target
+117.11%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
INTEGRATED DIAGNOSTICS HOLDINGS PLC Stock Integrated Diagnostics Holdings plc
-11.13% 189M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. IDHC Stock
  4. Financials Integrated Diagnostics Holdings plc